Intellectual property claims to stem cell technologies: research, clinical testing and product sales
A.M. Hammersla and M.L. Rohrbaugh, National Institutes of Health, USA
Abstract:
This chapter reviews the debates arising in national arenas throughout the industrialized world and among international organizations regarding the use and patentability of stem cells. These debates involve many stakeholders, including researchers, politicians, religious organizations, ethicists, policy makers, patent experts, court systems, patient advocacy groups and governments, leading to an international patchwork of stem cell patent laws. This patchwork of laws, conflicting goals of countries and researchers, and possible patent thickets have to some ...
Get Progenitor and Stem Cell Technologies and Therapies now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
